Skip to main content
Clinical Trials/JPRN-UMIN000027342
JPRN-UMIN000027342Recruiting未知

Development of hepatocellular carcinoma after hepatitis C virus eradication in interferon-free direct-acting antivirals - Development of hepatocellular carcinoma after direct-acting antivirals

Kyushu University0 sites2,000 target enrollmentStarted: May 15, 2017Last updated:
Conditions

Trial Snapshot

Phase
未知
Status
Recruiting
Enrollment
2,000

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Observational

Eligibility Criteria

Ages
20years-old to ot applicable (—)
Sex
All

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • (1) under age 20 at the initiation of treatment (2) decompensated cirrhosis with Child-Pugh B or C (3) concomitant human immunodeficiency virus or hepatitis B virus infection (4) excessive active alcohol consumption

Investigators

Similar Trials